Acurx Pharmaceuticals, Inc. (ACXP)
About Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$8.0M
- Total assets
- $7.7M
- Market cap
- $7.2M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $8.1M
- Operating income
- -$8.1M
- Net income
- -$8.0M
- EPS (basic)
- $-5.32
- EPS (diluted)
- $-5.32
Balance sheet
- Total assets
- $7.7M
- Current assets
- $7.7M
- Total liabilities
- $2.4M
- Current liabilities
- $2.4M
- Shareholders’ equity
- $5.3M
Cash flow
- Operating cash flow
- -$6.8M
- Investing cash flow
- -$3.8M
- Financing cash flow
- $10.6M
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $7.2M
- EPS (diluted)
- $-5.32
- Shares outstanding
- 4.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 25, 2021
Acurx Pharmaceuticals, Inc. (ACXP) Stock Price
- Reported a net loss of $8.0M.
- Trading 91% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Acurx Pharmaceuticals, Inc..
Write a review
News about Acurx Pharmaceuticals, Inc.
News & sentiment via Polygon.io
Acurx Pharmaceuticals, Inc.: frequently asked questions
Is Acurx Pharmaceuticals, Inc. an American company?
Acurx Pharmaceuticals, Inc. is a US-based company headquartered in Staten Island, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Acurx Pharmaceuticals, Inc. headquartered?
Acurx Pharmaceuticals, Inc. is headquartered in Staten Island, New York, United States.
Is Acurx Pharmaceuticals, Inc. publicly traded?
Yes — Acurx Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol ACXP on the NASDAQ.
What does Acurx Pharmaceuticals, Inc. do?
Acurx Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
